Freesolo Capital concentrates on lower middle market healthcare companies where we can pair operating playbooks with founder ambition. Our strategy is narrow on purpose — depth in four sectors over breadth across many.
We don't believe in passive capital. We believe in concentrated conviction, hands-on operating support, and a partnership that lasts longer than the fund's average holding period.
Within healthcare, we focus on segments with structural demand tailwinds, defensible margins, and platform potential. Below is what we look for in each.
Specialty practices, ambulatory care platforms, behavioral health, and post-acute services with proven unit economics and consolidation runway.
Revenue cycle management, clinical staffing, administrative services, and outsourced operations with embedded customer relationships.
CRO/CDMO niche providers, specialty pharmacy operations, commercialization services, and patient access platforms supporting drug development and delivery.
Platforms combining proprietary technology with managed services — where AI and ML can compound margin over the hold period without disrupting the founder's core offering.
From first conversation to long-term partnership, our process is designed to respect the founder's time and surface alignment quickly.
We source through operator networks, sector specialization, and direct relationships — not auctions. Most of our best leads come from founders we've worked with before.
Sharp diligence focused on the operating model, growth thesis, and founder fit. We tell you what we think — clearly and quickly — within two to three weeks of a first meeting.
Flexible structures designed around the founder's goals — control or significant minority, full liquidity or partial roll. We tailor terms to the situation, not the other way around.
Hands-on operating partnership: commercial expansion, M&A, talent, and AI/ML deployment. We work alongside the founder, not above them.
We exit when the company is genuinely better, larger, and more durable than when we partnered. Our reputation depends on outcomes for founders, employees, and patients.
We try to be direct about who we're built for — and who we're not. If you're not sure, reach out anyway. A short call usually settles it.